Ponezumab Biosimilar – Anti-APP Abeta40 mAb – Research Grade

Reference:
Product namePonezumab Biosimilar - Anti-APP Abeta40 mAb - Research Grade
SourceCAS 1178862-65-1
SpeciesHumanized
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsELISA,WB
Aliases /SynonymsPonezumab,PF-04360365,RN-1219,clone 9TL,APP Abeta40,anti-APP Abeta40
ReferencePX-TA1261
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG2-kappa
ClonalityMonoclonal Antibody

Description of Ponezumab Biosimilar - Anti-APP Abeta40 mAb - Research Grade

General information on Anti-APP Abeta40[Homo sapiens] (Ponezumab) Monoclonal Antibody

Ponezumab is investigated for the treatment of Mild To Moderate Alzheimer’s Disease.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Ponezumab Biosimilar – Anti-APP Abeta40 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Human APP (18-705) Recombinant Protein
Antigen

Human APP (18-705) Recombinant Protein

PX-P1059 221$
Human IgG2 Isotype Control antibody (HyHEL-10)
Isotype Control

Human IgG2 Isotype Control antibody (HyHEL-10)

PTX17900 189$
Stable Isotope Labelled Ponezumab Biosimilar – Anti-APP Abeta40 mAb – Research Grade
SIL

Stable Isotope Labelled Ponezumab Biosimilar – Anti-APP Abeta40 mAb – Research Grade

PX-TA1261-SIL 15750$

Contact us

Send us a message from the form below







    Cart (0 Items)

    Your cart is currently empty.

    View Products